zoledronic acid has been researched along with Body Weight in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (50.00) | 29.6817 |
| 2010's | 8 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, X; Lu, E; Mao, C; Qin, A; Xu, X; Zhang, X | 1 |
| Aguirre, JI; Bhattacharyya, N; Castillo, EJ; Jiron, JM; Kimmel, DB; Mendieta Calle, JL; Messer, JG; Van Poznak, C | 1 |
| Allen, MR; Aref, MW; Chen, N; Hammond, MA; Lehmkuhler, DR; Metzger, CE; Moe, SM; Nickolas, TL; Sacks, S; Swallow, EA; Territo, PR | 1 |
| Chang, SX; Li, GW; Nian, H; Shi, X; Wang, XY; Xu, Z; Zhou, L | 1 |
| Brüel, A; Henriksen, K; Thomsen, JS; Vegger, JB; Wendelboe, MH | 1 |
| Ato, M; Iwagami, M; Kano, S; Ota, N; Seki, T; Yamamoto, K | 1 |
| Briody, J; Cowell, CT; Johannesen, J; Little, DG; McQuade, M; Munns, CF | 1 |
| Beaupied, H; Benhamou, CL; Courteix, D; Dolléans, E; Jaffré, C; Lespessailles, E; Nanyan, P | 1 |
| Ince, C; Lindeboom, JA; Milstein, DM | 1 |
| Chang, SX; Fan, JZ; He, YM; Li, GW; Tian, YN; Xu, Z | 1 |
| Boulet, JM; Bunton, TE; Sellers, R; Walker, K; Whiteside, GT | 1 |
| Atzpodien, E; Bauss, F; Bohrmann, B; Pfister, T | 1 |
| Bhatnagar, AS; Evans, DB; Gasser, JA; Green, JR; Ingold, P; Rebmann, A; Shen, V | 1 |
| Gondo, T; Hashimoto, T; Matsunaga, T; Shigetomi, M; Sugiyama, T; Suzuki, H; Taguchi, T; Tanaka, H | 1 |
| Dai, R; Guo, H; Li, S; Liao, E; Liu, J; Sheng, Z; Wen, G; Wu, X; Xu, K | 1 |
| Corey, E; Gross, TS; Morgan, TM; Pitts, TE; Poliachik, SL; Vessella, RL | 1 |
16 other study(ies) available for zoledronic acid and Body Weight
| Article | Year |
|---|---|
Bis‑enoxacin blocks alveolar bone resorption in rats with ovariectomy‑induced osteoporosis.
Topics: Alveolar Bone Loss; Animals; Body Weight; Bone and Bones; Bone Density Conservation Agents; Diphosphonates; Disease Models, Animal; Enoxacin; Female; Imidazoles; Microscopy, Fluorescence; Osteoporosis; Ovariectomy; Rats; Rats, Sprague-Dawley; X-Ray Microtomography; Zoledronic Acid | 2018 |
Zoledronic acid increases the prevalence of medication-related osteonecrosis of the jaw in a dose dependent manner in rice rats (Oryzomys palustris) with localized periodontitis.
Topics: Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Body Weight; Bone Resorption; Dose-Response Relationship, Drug; Female; Femur; Osteocytes; Periodontitis; Prevalence; Sigmodontinae; Treatment Outcome; Zoledronic Acid | 2018 |
Skeletal levels of bisphosphonate in the setting of chronic kidney disease are independent of remodeling rate and lower with fractionated dosing.
Topics: Animals; Body Weight; Bone and Bones; Bone Remodeling; Diphosphonates; Dose-Response Relationship, Drug; Fluorescence; Male; Osteogenesis; Rats; Renal Insufficiency, Chronic; Tibia; Zoledronic Acid | 2019 |
Influence of early zoledronic acid administration on bone marrow fat in ovariectomized rats.
Topics: Adipocytes; Adipogenesis; Adiposity; Animals; Body Weight; Bone Density; Bone Density Conservation Agents; Bone Marrow; Bone Remodeling; Diphosphonates; Female; Imidazoles; Longitudinal Studies; Ovariectomy; Random Allocation; Rats, Sprague-Dawley; Uterus; Zoledronic Acid | 2014 |
Zoledronate prevents lactation induced bone loss and results in additional post-lactation bone mass in mice.
Topics: Absorptiometry, Photon; Alkaline Phosphatase; Animals; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Diphosphonates; Female; Femur; Fractures, Bone; Imidazoles; Lactation; Mice; Organ Size; Osteogenesis; Tartrate-Resistant Acid Phosphatase; Weaning; X-Ray Microtomography; Zoledronic Acid | 2016 |
Dual antiplasmodial activity of vitamin D3 and its analog, 22-oxacalcitriol, by direct and indirect mechanisms.
Topics: Acute Disease; Animals; Antimalarials; Body Weight; Calcitriol; Cholecalciferol; Chronic Disease; Diphosphonates; Erythrocytes; Humans; Hypercalcemia; Imidazoles; Interferon-gamma; Malaria; Mice; Mice, Inbred BALB C; Mice, Knockout; Parasitemia; Plasmodium chabaudi; Receptors, Calcitriol; Zoledronic Acid | 2017 |
Systemic effects of zoledronic acid in children with traumatic femoral head avascular necrosis and Legg-Calve-Perthes disease.
Topics: Absorptiometry, Photon; Body Height; Body Mass Index; Body Weight; Bone Density Conservation Agents; Child; Cohort Studies; Densitometry; Diphosphonates; Epiphyses; Female; Humans; Imidazoles; Legg-Calve-Perthes Disease; Male; Retrospective Studies; Wounds and Injuries; Zoledronic Acid | 2009 |
Does exercise modify the effects of zoledronic acid on bone mass, microarchitecture, biomechanics, and turnover in ovariectomized rats?
Topics: Animals; Biomarkers; Body Weight; Bone and Bones; Bone Density; Bone Density Conservation Agents; Collagen Type I; Diphosphonates; Female; Imidazoles; Osteocalcin; Osteogenesis; Ovariectomy; Peptide Fragments; Peptides; Physical Conditioning, Animal; Procollagen; Rats; Rats, Wistar; Stress, Mechanical; Tomography, X-Ray Computed; Zoledronic Acid | 2009 |
The influence of zoledronic acid and cyclophosphamide on microcirculation regeneration in healing oral mucosal flaps.
Topics: Analysis of Variance; Animals; Blood Cell Count; Body Weight; Cyclophosphamide; Diphosphonates; Female; Imidazoles; Microcirculation; Mouth Mucosa; Rabbits; Random Allocation; Regeneration; Surgical Flaps; Wound Healing; Zoledronic Acid | 2011 |
Marrow adiposity recovery after early zoledronic acid treatment of glucocorticoid-induced bone loss in rabbits assessed by magnetic resonance spectroscopy.
Topics: Absorptiometry, Photon; Adipocytes; Adiposity; Animals; Body Weight; Bone Density; Bone Marrow; Bone Marrow Cells; Bone Resorption; Diphosphonates; Female; Femur; Glucocorticoids; Imidazoles; Lipids; Magnetic Resonance Spectroscopy; Rabbits; Reproducibility of Results; Zoledronic Acid | 2013 |
Neuropathy-induced osteopenia in rats is not due to a reduction in weight born on the affected limb.
Topics: Alendronate; Animals; Body Weight; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Diphosphonates; Hyperalgesia; Imidazoles; Ligation; Male; Neuralgia; Physical Stimulation; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Stress, Mechanical; Treatment Outcome; Zoledronic Acid | 2006 |
Acute renal effects of intravenous bisphosphonates in the rat.
Topics: Animals; Body Weight; Bone Density Conservation Agents; Clodronic Acid; Diphosphonates; Female; Ibandronic Acid; Imidazoles; Injections, Intravenous; Kidney; Rats; Rats, Inbred Strains; Zoledronic Acid | 2005 |
A single intravenous administration of zoledronic acid prevents the bone loss and mechanical compromise induced by aromatase inhibition in rats.
Topics: Animals; Aromatase Inhibitors; Biomechanical Phenomena; Body Weight; Bone and Bones; Bone Density; Bone Density Conservation Agents; Diphosphonates; Estrogens; Female; Imidazoles; Injections, Intravenous; Letrozole; Nitriles; Organ Size; Osteocalcin; Osteoporosis; Ovariectomy; RANK Ligand; Rats; Rats, Wistar; Triazoles; Uterus; Zoledronic Acid | 2006 |
Effects of bisphosphonate treatment on bone repair under immunosuppression using cyclosporine A in adult rats.
Topics: Animals; Biomarkers; Body Weight; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Bone Resorption; Bone Transplantation; Cyclosporine; Diphosphonates; Drug Interactions; Fractures, Bone; Graft Survival; Imidazoles; Immunosuppressive Agents; Male; Osteogenesis; Osteoporosis; Rats; Rats, Inbred Lew; Tibia; Zoledronic Acid | 2007 |
Comparison of the effects of genistein and zoledronic acid on the bone loss in OPG-deficient mice.
Topics: Acid Phosphatase; Alkaline Phosphatase; Animals; Biomechanical Phenomena; Body Weight; Bone Density; Bone Remodeling; Bone Resorption; Diphosphonates; Dose-Response Relationship, Drug; Endometrium; Estradiol; Female; Femur; Genistein; Genotype; Imidazoles; Isoenzymes; Liver; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mice, Knockout; Osteoprotegerin; RANK Ligand; Tartrate-Resistant Acid Phosphatase; Tibia; Uterus; Zoledronic Acid | 2008 |
RAD001 (Everolimus) inhibits growth of prostate cancer in the bone and the inhibitory effects are increased by combination with docetaxel and zoledronic acid.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Diphosphonates; Docetaxel; Everolimus; Humans; Imidazoles; Male; Mice; Prostatic Neoplasms; Protein Kinase Inhibitors; Protein Kinases; Sirolimus; Taxoids; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Zoledronic Acid | 2008 |